Brian Goff, Chief Executive Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 18,703 shares at $27.09 ($507K) on 2025-12-30, disclosed to the SEC on 2026-01-02.
Open-market sale of $507k AGIO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.09 | 6,230 | $169K | 33.3% |
| 2 | $27.09 | 12,473 | $338K | 66.7% |
| Total | $27.09 avg | 18,703 | $507K | 100% |
| Filing → |
| AGIO | SELL | 2025-08-12 | $813K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $1.3M | — | Filing → |
| AGIO | SELL | 2025-03-04 | $920K | — | Filing → |